The U.S. Food and Drug Administration (FDA) has warned healthcare providers about a cybersecurity vulnerability in Illumina’s sequencing instruments. The vulnerability could allow bad actors to compromise the devices, alter software and patient test results, or access protected data. The FDA is urging device owners to review recall notices, install patches, and contact Illumina for support. Genomic data breaches are a significant concern due to the potential risks to patient safety, data confidentiality, and care delivery. The FBI is also urging healthcare organizations to address medical device cybersecurity.
Hazy Hawk Exploits Organizations’ DNS Gaps to Abuse Cloud Resources & Deliver Malware
Security researchers have identified a threat actor called “Hazy Hawk” that is hijacking abandoned cloud resources from prominent organisations to distribute scams and malware. The
